Dahlrot RH - Search Results

1

Evolution of the gross tumour volume extent during radiotherapy for glioblastomas.

Bernchou U, Arnold TST, Axelsen B, Klüver-Kristensen M, Mahmood F, Harbo FSG, Asmussen JT, Hansen O, Bertelsen AS, Hansen S, Brink C, Dahlrot RH. Bernchou U, et al. Among authors: dahlrot rh. Radiother Oncol. 2021 Jul;160:40-46. doi: 10.1016/j.radonc.2021.04.001. Epub 2021 Apr 20. Radiother Oncol. 2021. PMID: 33848564

2

MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

Hermansen SK, Dahlrot RH, Nielsen BS, Hansen S, Kristensen BW. Hermansen SK, et al. Among authors: dahlrot rh. J Neurooncol. 2013 Jan;111(1):71-81. doi: 10.1007/s11060-012-0992-3. Epub 2012 Oct 28. J Neurooncol. 2013. PMID: 23104517

3

A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.

Dahlrot RH, Kristensen BW, Hjelmborg J, Herrstedt J, Hansen S. Dahlrot RH, et al. Int J Clin Exp Pathol. 2013;6(1):31-40. Epub 2012 Nov 20. Int J Clin Exp Pathol. 2013. PMID: 23236540 Free PMC article.

4

What is the clinical value of cancer stem cell markers in gliomas?

Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW. Dahlrot RH, et al. Int J Clin Exp Pathol. 2013;6(3):334-48. Epub 2013 Feb 15. Int J Clin Exp Pathol. 2013. PMID: 23412423 Free PMC article. Review.

5

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).

Dahlrot RH, Kristensen BW, Hjelmborg J, Herrstedt J, Hansen S. Dahlrot RH, et al. J Neurooncol. 2013 Sep;114(3):309-17. doi: 10.1007/s11060-013-1186-3. Epub 2013 Jul 2. J Neurooncol. 2013. PMID: 23817809

6

Prognostic value of Musashi-1 in gliomas.

Dahlrot RH, Hansen S, Herrstedt J, Schrøder HD, Hjelmborg J, Kristensen BW. Dahlrot RH, et al. J Neurooncol. 2013 Dec;115(3):453-61. doi: 10.1007/s11060-013-1246-8. Epub 2013 Sep 21. J Neurooncol. 2013. PMID: 24057325

7

Clinical value of CD133 and nestin in patients with glioma: a population-based study.

Dahlrot RH, Hansen S, Jensen SS, Schrøder HD, Hjelmborg J, Kristensen BW. Dahlrot RH, et al. Int J Clin Exp Pathol. 2014 Jun 15;7(7):3739-51. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25120750 Free PMC article.

8

Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.

Dahlrot RH, Sørensen MD, Rosager AM, Hellwege S, Bangsø JA, Rosenberg T, Petterson SA, Klitkou J, Fosmark S, Hansen S, Kristensen BW. Dahlrot RH, et al. CNS Oncol. 2014 Jul;3(4):287-98. doi: 10.2217/cns.14.30. CNS Oncol. 2014. PMID: 25286040 Free PMC article.

9

High levels of c-Met is associated with poor prognosis in glioblastoma.

Petterson SA, Dahlrot RH, Hermansen SK, K A Munthe S, Gundesen MT, Wohlleben H, Rasmussen T, Beier CP, Hansen S, Kristensen BW. Petterson SA, et al. Among authors: dahlrot rh. J Neurooncol. 2015 May;122(3):517-27. doi: 10.1007/s11060-015-1723-3. Epub 2015 Mar 24. J Neurooncol. 2015. PMID: 25800004

10

Expression and prognostic value of the WEE1 kinase in gliomas.

Music D, Dahlrot RH, Hermansen SK, Hjelmborg J, de Stricker K, Hansen S, Kristensen BW. Music D, et al. Among authors: dahlrot rh. J Neurooncol. 2016 Apr;127(2):381-9. doi: 10.1007/s11060-015-2050-4. Epub 2016 Jan 6. J Neurooncol. 2016. PMID: 26738845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page